SPDR S&P Pharmaceuticals ETF (XPH)
- Previous Close
39.09 - Open
39.06 - Bid 38.76 x 1300
- Ask 39.62 x 1800
- Day's Range
39.06 - 39.65 - 52 Week Range
34.67 - 45.62 - Volume
12,150 - Avg. Volume
36,698 - Net Assets 219.96M
- NAV 39.08
- PE Ratio (TTM) 14.23
- Yield 1.37%
- YTD Daily Total Return -5.69%
- Beta (5Y Monthly) 0.66
- Expense Ratio (net) 0.35%
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
SPDR State Street Global Advisors
Fund Family
Health
Fund Category
219.96M
Net Assets
2006-06-19
Inception Date
Performance Overview: XPH
Trailing returns as of 4/25/2024. Category is Health.
People Also Watch
Holdings: XPH
Top 10 Holdings (46.53% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: XPH
VRSN: Raising target price to $194.00
VERISIGN INC has an Investment Rating of HOLD; a target price of $194.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAnalyst Report: ASML Holding N.V.
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.
RatingPrice TargetVRSN: Raising target price to $201.00
VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAnalyst Report: Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
RatingPrice Target